GLP-1 agonists and gastrointestinal adverse events
Any use should be framed as investigational with appropriate informed consent and outcome tracking
[I] take a liposomal version internally
The anal sphincters relax during a bowel movement, permitting stool to exit while maintaining a barrier against unwanted leakage at other times
In this video, James Hathcock walks through where uncertainty sits today around PFAS in bioprocess filtration, from PVDF and PTFE to PES, and how this relates to current ECHA proposals
Camacho-Pereira J, Tarrago MG, Chini CCS, Nin V, Escande C, Warner GM, et al